Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genakumab vs etoricoxib in acute gouty arthritis
CTR20231863Phase 2Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jun 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of genakumab in acute gout flare, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jun 2023; status: completed.
02
Drugs
genakumab
03
Conditions
acute gout flare
Beyond the preview
Go deeper on CTR20231863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231863.